Sonoma Pharmaceuticals Inc expected to post a loss of 6 cents a share - Earnings Preview

Sonoma Pharmaceuticals

07/08/2024 03:04

* Sonoma Pharmaceuticals Inc  SNOA.OQ   SNOA.O  is expected
to show a rise in quarterly revenue when it reports  results on
August 8 (estimated) for the period ending June 30 2024
    * The Boulder Colorado-based  company is expected to report
a
15.0% increase in revenue to $3.94 million from $3.43 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Sonoma Pharmaceuticals
Inc is
for a loss of 6 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The average consensus recommendation for
the pharmaceuticals
peer group is also "Strong Buy".​
    * Wall Street's median 12-month price target for Sonoma
Pharmaceuticals Inc is $1.50​, above​ its last closing price
of $0.30. ​​​

This summary was machine generated August 7 at 02:04 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)